Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 46, Issue 3 (Mar 2008)

Issues

Size distribution of circulating cell-free DNA in sera of breast cancer patients in the course of adjuvant chemotherapy

Ugur Deligezer / Yesim Eralp / Ebru E. Akisik / Elif Z. Akisik / Pinar Saip / Erkan Topuz / Nejat Dalay
Published Online: 2008-02-06 | DOI: https://doi.org/10.1515/CCLM.2008.080

Abstract

Background: The integrity of circulating cell-free DNA (cf-DNA) in serum or plasma appears to be of diagnostic and prognostic value in cancer. Here, we investigated the dynamics of serum DNA levels and the size distribution of cf-DNA during adjuvant chemotherapy of patients with breast cancer (n=73).

Methods: By evaluating sera taken at the beginning and the end of the adjuvant chemotherapy, variations of serum DNA levels and the size distribution were analyzed, based on quantification of shorter apoptotic and longer non-apoptotic fragments from abundant genomic ALU fragments amplified by quantitative real-time PCR.

Results: The mean DNA level did not change significantly during chemotherapy. However, individual cases revealed considerable variation in the amount of serum DNA. It increased in 43.8% of the patients, whereas it decreased in the remaining majority (56.2%). By calculating a “coefficient of variation” (both decrease and increase) in the level of total DNA and non-apoptotic DNA fragments, we compared the values at the beginning and the end of the therapy. For total DNA, the range was between 1.02- and 26-fold (mean 3.76-fold), whereas for non-apoptotic fragments it ranged from 1.01- to 73-fold (mean 6.9-fold) (p=0.033). In accordance with these findings, the integrity of serum DNA was higher in patients with increasing DNA levels and vice versa.

Conclusions: Our findings suggest that non-apoptotic fragments contribute to a higher degree to the change of the DNA level during adjuvant chemotherapy.

Clin Chem Lab Med 2008;46:311–7.

Keywords: adjuvant therapy; breast cancer; cell-free DNA; serum; size distribution

About the article

Corresponding author: Dr. Ugur Deligezer, Department of Basic Oncology, Oncology Institute, 34390 Capa/Istanbul, Turkey Phone: +90-212-4142434, Fax: +90-212-5348078,


Received: 2007-09-03

Accepted: 2007-11-20

Published Online: 2008-02-06

Published in Print: 2008-03-01


Citation Information: Clinical Chemical Laboratory Medicine, ISSN (Online) 14374331, ISSN (Print) 14346621, DOI: https://doi.org/10.1515/CCLM.2008.080.

Export Citation

©2008 by Walter de Gruyter Berlin New York. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Heidi Schwarzenbach
Breast Cancer Research, 2013, Volume 15, Number 5
[2]
Sarah Breitbach, Suzan Tug, Susanne Helmig, Daniela Zahn, Thomas Kubiak, Matthias Michal, Tommaso Gori, Tobias Ehlert, Thomas Beiter, Perikles Simon, and Tom Gilbert
PLoS ONE, 2014, Volume 9, Number 3, Page e87838
[3]
Florent Mouliere, Bruno Robert, Erika Arnau Peyrotte, Maguy Del Rio, Marc Ychou, Franck Molina, Celine Gongora, Alain R. Thierry, and Terence Lee
PLoS ONE, 2011, Volume 6, Number 9, Page e23418
[4]
Abel Jacobus Bronkhorst, Johannes F. Wentzel, Janine Aucamp, Etresia van Dyk, Lissinda du Plessis, and Piet J. Pretorius
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2016, Volume 1863, Number 1, Page 157
[5]
Dharanija Madhavan, Markus Wallwiener, Karin Bents, Manuela Zucknick, Juliane Nees, Sarah Schott, Katarina Cuk, Sabine Riethdorf, Andreas Trumpp, Klaus Pantel, Christof Sohn, Andreas Schneeweiss, Harald Surowy, and Barbara Burwinkel
Breast Cancer Research and Treatment, 2014, Volume 146, Number 1, Page 163
[6]
Mariangela Zane, Marco Agostini, Maria Vittoria Enzo, Eric Casal Ide, Paola Del Bianco, Francesca Torresan, Isabella Merante Boschin, Gianmaria Pennelli, Andrea Saccani, Domenico Rubello, Donato Nitti, and Maria Rosa Pelizzo
Biomedicine & Pharmacotherapy, 2013, Volume 67, Number 8, Page 723
[7]
Pâmela Oliveira Delgado, Beatriz Costa A. Alves, Flávia de Sousa Gehrke, Renata Kelly Kuniyoshi, Marcelo Langer Wroclavski, Auro Del Giglio, and Fernando Luiz Affonso Fonseca
Tumor Biology, 2013, Volume 34, Number 2, Page 983
[8]
Florent Mouliere and Alain R Thierry
Expert Opinion on Biological Therapy, 2012, Volume 12, Number sup1, Page S209
[9]
Shiyang Pan, Wenying Xia, Qingqing Ding, Yongqian Shu, Ting Xu, Yan Geng, Yachun Lu, Dan Chen, Jian Xu, Fang Wang, Chun Zhao, Peijun Huang, Puwen Huang, Hongbing Shen, Zhibin Hu, and Shan Lu
Biomedicine & Pharmacotherapy, 2012, Volume 66, Number 2, Page 131
[10]
Sandi Kwee, Min-Ae Song, Iona Cheng, Lenora Loo, and Maarit Tiirikainen
Clinical and Translational Science, 2012, Volume 5, Number 1, Page 65
[11]
Klaus Jung, Michael Fleischhacker, and Anja Rabien
Clinica Chimica Acta, 2010, Volume 411, Number 21-22, Page 1611
[12]
Marco Agostini, Salvatore Pucciarelli, Maria Vittoria Enzo, Paola Del Bianco, Marta Briarava, Chiara Bedin, Isacco Maretto, Maria Luisa Friso, Sara Lonardi, Claudia Mescoli, Paola Toppan, Emanuele Urso, and Donato Nitti
Annals of Surgical Oncology, 2011, Volume 18, Number 9, Page 2461
[13]
I. Yu. Strelkova, S. A. Abdullaev, G. P. Snigireva, V. G. Bezlepkin, and A. I. Gaziev
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 2011, Volume 5, Number 1, Page 88
[14]
Yu-Jie Gao, Yu-Juan He, Zai-Lin Yang, Hui-Yuan Shao, Yan Zuo, Yao Bai, Hui Chen, Xian-Chun Chen, Feng-Xian Qin, Shi Tan, Jian Wang, Li Wang, and Ling Zhang
Clinical Chemistry and Laboratory Medicine, 2010, Volume 48, Number 11
[15]
Jacqui A Shaw, James Brown, R Charles Coombes, Jimmy Jacob, Rachel Payne, Belinda Lee, Karen Page, Natasha Hava, and Justin Stebbing
Biomarkers in Medicine, 2011, Volume 5, Number 1, Page 87
[16]
Simon R. Corrie, Pavel Sova, Qinghua Feng, Tiffany Blair, Nancy B. Kiviat, and Matt Trau
The Analyst, 2011, Volume 136, Number 4, Page 688
[17]
Bozena Dobrzycka, Slawomir J. Terlikowski, Andrzej Mazurek, Oksana Kowalczuk, Wieslawa Niklinska, Lech Chyczewski, and Marek Kulikowski
International Journal of Cancer, 2010, Volume 127, Number 3, Page 612
[18]
Chao Cheng, Motoko Omura-Minamisawa, Yun Kang, Takamitsu Hara, Izumi Koike, and Tomio Inoue
Cancer Science, 2009, Volume 100, Number 2, Page 303

Comments (0)

Please log in or register to comment.
Log in